Pettinga Financial Advisors, LLC Pfizer Inc Transaction History

Pettinga Financial Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 27, 2022	SELL	$45.75 - $56.69 $180,621 - $223,812	-3,948 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$41.32 - $61.25 $80,326 - $119,070	-1,944 Reduced 32.99%	3,948 $233,000
Q3 2021 Oct 29, 2021	BUY	$39.25 - $50.42 $231,261 - $297,074	5,892 New	5,892 $253,000
Q3 2019 Oct 17, 2019	SELL	$32.49 - $42.13 $150,363 - $194,977	-4,628 Closed	0 $0
Q2 2019 Jul 31, 2019	BUY	$36.98 - $41.52 $171,143 - $192,154	4,628 New	4,628 $201,000

Q1 2019 May 13, 2019	SELL	$37.5 - $41.2 $173,512 - $190,632	-4,627 Closed	0 $0
Q4 2018 Feb 01, 2019	BUY	$38.47 - $43.86 $178,000 - $202,940	4,627 New	4,627 $202,000

3,159

3.68B

67.4M

113M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Pettinga Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Pettinga Financial Advisors, LLC with notifications on news.